Share
593 Posts.
lightbulb Created with Sketch. 2
clock Created with Sketch.
14/03/23
10:23
Share
Originally posted by Rajenp5:
↑
'At the time, QBiotics was valued about $680 million. A share market float was planned for 2022. One of Australia’s most-sought-after directors, former Macquarie chief executive Nicholas Moore, joined the board' 'QBiotics added that Mr Moore had resigned from the board. Ms George said his resignation and timing of the trial change were a coincidence. Mr Moore declined to comment on the reasons for his departure' There are some inaccuracies in the article though, some lazy journalism. For instance, wtf is Victoria George? That article seemingly nothing but bad news especially for investors who have hung in or rather been trapped since the 'sizzle' stage. Middle of the month and no share transfer summary. Their gas lighting continues
Expand
On the bright side... Pfizer has announced the acquisition of Seagen for $US43 billion. Seagen has revenues of around US$2 billion per annum so 20X revenue. Seagen has never made a profit. Something to inspire founders and management.